ARTELO BIOSCIENCES
Artelo Biosciences is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. Its programmes have the potential to dramatically improve patient care in major markets.
ARTELO BIOSCIENCES
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2011-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.artelobio.com
Total Employee:
1+
Status:
Active
Contact:
+1 760 943 1689
Email Addresses:
[email protected]
Total Funding:
8.06 M USD
Technology used in webpage:
Google Maps Amazon HSTS Apache Pound Sterling CloudFront PostalAddress Schema Amazon S3 CDN Linode Amazon Frankfurt Region
Similar Organizations
Castle Creek Biosciences
Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Advisors List
Current Employees Featured
Stock Details
Key Employee Changes
| Date | New article |
|---|---|
| 2021-02-16 | Artelo Biosciences names Andrew Yates as chief scientific officer |
Official Site Inspections
http://www.artelobio.com Semrush global rank: 2.82 M Semrush visits lastest month: 5.97 K
- Host name: harry.wordkeeper.net
- IP address: 45.33.30.181
- Location: Dallas United States
- Latitude: 32.7787
- Longitude: -96.8217
- Metro Code: 623
- Timezone: America/Chicago
- Postal: 75270
More informations about "Artelo Biosciences"
About - Artelo Biosciences
Artelo Biosciences is a clinical stage company using cutting-edge science to improve patient care. We were founded in 2017 on the promise of therapeutic development based on lipid-signaling …See details»
Artelo Biosciences, Inc. (ARTL)
Nov 12, 2024 Artelo Biosciences, Inc. is a clinical stage pharmaceutical company dedicated to the development and commercialization of proprietary therapeutics that modulate lipid-signaling pathways including the …See details»
Company Information :: Artelo Biosciences, Inc. (ARTL)
Company Contact Artelo Biosciences, Inc. 505 Lomas Santa Fe Drive Suite 160 Solana Beach, CA 92075See details»
News & Events - Artelo Biosciences, Inc.
Jan 8, 2024 Worldwide Clinical Trials (Worldwide) is a leading full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical …See details»
Management - Artelo Biosciences
Steven D. Reich, MD has served as our Chief Medical Officer since April 2018. Dr. Reich brought to Artelo over four decades of drug research experience, both as an academically based investigator for Phase I-III trials and as a senior …See details»
Artelo Biosciences - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +1 760 943 1689 Artelo Biosciences is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past …See details»
Artelo Biosciences, Inc. | LinkedIn
Ir.artelobio.com 27 2 Comments Like Comment Share Artelo Biosciences, Inc. 1,594 followers 6d Report this post https://lnkd.in/gtbA4i3p #CancerCare # ...See details»
Board of Directors - Artelo Biosciences
Greg Reyes, MD, PhD, was elected to our board November 2020. Dr. Reyes brings 35 years experience in biotech and large pharma to Artelo. Past leadership positions include overseeing …See details»
Artelo Biosciences Announces Selection of Worldwide
Jan 8, 2024 Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12 January 08, 2024 08:30 …See details»
News & Events - Artelo Biosciences, Inc.
Jul 15, 2024 Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the Company applies leading-edge scientific, regulatory, …See details»
Artelo Biosciences Announces Selection of Worldwide Clinical …
Jan 8, 2024 Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12 Artelo Biosciences Mon, …See details»
Science - Artelo Biosciences
July 02, 2024 – ICRS 2024. ART26.12, a Novel Fatty Acid-Binding Protein 5 Inhibitor, Shows Efficacy in Preclinical Models of Psoriasis (PDF, 1.15MB) presented by George Warren. …See details»
Artelo Biosciences Receives FDA Clearance of its IND Application …
Jul 15, 2024 Artelo Biosciences. ART26.12 seeks to address a critical need in painful neuropathies, including chemotherapy-induced peripheral neuropathy for which there is no …See details»
Artelo Biosciences Announces Selection of Aptus Clinical Ltd. as ...
Oct 29, 2019 More information is available at www.artelobio.com and Twitter: @ArteloBio. About Aptus Clinical Ltd. Aptus Clinical Limited is a clinical contract research organization that …See details»
Artelo Biosciences Receives FDA Clearance of its IND
Jul 15, 2024 Study startup activities have been initiated in collaboration with the internationally known contract research organization Worldwide Clinical Trials. ... @ArteloBio. Forward …See details»
Investors - Artelo Biosciences
For corporate governance documents, please see this page.The Company announces material financial information to its investors using SEC filings, press releases, public webcasts and …See details»
News & Events - ir.artelobio.com
Nov 5, 2024 More information is available at www.artelobio.com and Twitter: @ArteloBio. Forward Looking Statements. This press release contains certain forward-looking statements …See details»
Artelo Biosciences Announces Promising New Data on Novel
Nov 13, 2024 According to the World Health Organization, OA affects over 500 million people globally. ... @ArteloBio. About Stony Brook University. Stony Brook University, New York’s …See details»
Artelo Biosciences Announces Promising New Data on Novel Non …
Nov 13, 2024 According to the World Health Organization, OA affects over 500 million people globally. Symptoms of OA include joint debilitation and persistent, extreme pain. Artelo’s …See details»